Delivery Order SPE2DB22D2211-SPE2DB25FRXPQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets in a quantity of 30 units, with a ceiling value of $11,432.00. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of October 8, 2025. The award was issued on October 7, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.83 to AmerisourceBergen Drug Corp for 30 tablets of ADDYI 100 mg on September 18, 2025, with completion scheduled for September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,454.99 on September 16, 2025, for the supply of ADDYI 100 mg tablets in packages of 30. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as one of the nation's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.19 to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $35,858.57 to AmerisourceBergen Drug Corp for supply of ADDYI 100 mg tablets in quantities of 30-count units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $4,889.15 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADDYI 100 MG TABLET pharmaceuticals. The $3,199.38 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) on August 21, 2025, with a ceiling value of $7,861.63 and an ultimate completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRXPQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,758.26 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets in quantities of 30 units. This contract, which was competitively awarded without a set-aside designation, was executed on May 20, 2025, with an ultimate completion date of May 21, 2025, and will be performed in Conshohocken, Pennsylvania. The firm fixed price delivery order structure reflects DLA's standard pharmaceutical procurement methodology for medical supply chain distribution to support military and federal healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of pharmaceutical products and medical supplies. The company's DLA IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling delivery to Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 5/20/25 |